Riskpilot← Back to searchSign inGet full accessKLINIKK FROGNER AS
ASActiveOrg 988606014Skovveien 4, 0257 OsloOther human health activities n.e.c. · NACE 8699Est. 20058 employees
Revenue 2024
NOK 5,5M
+9% vs 2023
EBITDA margin
13.4%
+58% vs 2023
Equity ratio
65.2%
Financial strength
Net profit 2024
NOK 527K
+68% vs 2023
| Revenue | NOK 5,5M | +9% |
| EBITDA | NOK 733K | +58% |
| Net profit | NOK 527K | +68% |
| Total assets | NOK 2,3M | +36% |
| Equity | NOK 1,5M | +9% |
| Employees | 8 | — |
Legal name
KLINIKK FROGNER AS
Org number
988606014
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
5. september 2005
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Behandle og terapeutisk virksomhet og alt som står i den forbindelse.
Address
Skovveien 4, 0257 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 723 | 3 876 | 4 466 | 5 029 | 5 473 |
| Staff expenses | −849 | −967 | −1 220 | −1 242 | −1 251 |
| EBITDA | 582 | 358 | 396 | 463 | 733 |
| Depreciation & amort. | −65 | −51 | −44 | −61 | −56 |
| EBIT | 517 | 307 | 351 | 402 | 677 |
| Net financials | −12 | −0 | 0 | 0 | −1 |
| Profit before tax | 505 | 307 | 352 | 402 | 676 |
| Tax | 111 | 74 | 81 | 89 | 149 |
| Net profit | 394 | 233 | 271 | 313 | 527 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 926 | 1 054 | 1 370 | 1 700 | 2 312 |
| Equity | 564 | 798 | 1 068 | 1 381 | 1 508 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 362 | 257 | 302 | 319 | 804 |
| Total debt | 362 | 257 | 302 | 319 | 804 |
EBITDA margin
13.4%
This company
15.8%
Market median
-15% vs market
20202024
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
20202024
Return on equity
34.9%
This company
18.4%
Market median
+90% vs market
20202024
Net profit margin
9.6%
This company
8.1%
Market median
+19% vs market
20202024
Asset turnover
2.37×
This company
1.12×
Market median
+112% vs market
20202024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HB Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Deputy Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 67.5% | 67.5% | 2023 | |
| Company | 22.5% | 22.5% | 2023 | |
| Individual | 5% | 5% | 2023 | |
| Individual | 5% | 5% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLINIKK FROGNER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Bråthen Lund | Chief Executive Officer | 0 companies |
| Marianne Elena Molnes | Chairman | 0 companies |
| Helle Therese Finstad Hansen | Board of Directors | 0 companies |
| Tor Arne Grytbakk | Deputy Chairman | 0 companies |